2021-2022 Annual Report | VCU Massey Comprehensive Cancer Center

MASSEY V I R G I N I A C O M M O N W E A LT H U N I V E R S I T Y

2021-2022 ANNUAL REPORT

COMPREHENSIVE CANCER CENTER

An unwavering commitment Every day, Massey researchers, clinicians and staff are working to eliminate the burden of cancer and improve survivorship for all.

| 1

Message from the president VCU Massey Cancer Center’s quest for comprehensive status has been a top priority for the VCU enterprise for most of my tenure as president. A solid foundation was in place, thanks to the immeasurable leadership and transformation of the center under Dr. Gordon Ginder for more than two decades, Dr. I. David Goldman before him, and Dr. Walter Lawrence, Jr., Massey’s founding director. In 2018, VCU began a national search for a new director of the cancer center, and I knew with teamwork and a shared vision, our quest was within reach.

The first time I met Dr. Winn, I was immediately sure that he was the right leader at just the right time. We immediately resonated on the ‘why’ — what the highest recognition from the National Cancer Institute would mean for the people of the commonwealth and how a community-focused approach would help us get where we were going.

When Dr. Winn began his tenure in December 2019, we were unclear about the unprecedented public health crisis that would forever impact health care. I am proud of Dr. Winn and all of our VCU Massey team for responding to that challenge with poise and innovation. Not only did we effectively serve our patients, Massey’s commitment to the community was surpassed through initiatives like Facts & Faith Fridays.

Amidst the pandemic, our leading cancer center was also preparing for its competitive renewal from the National Cancer Institute. The process is arduous and often takes 18 to 24 months of preparation. How would this look during a global pandemic? How would we tackle these two monumental challenges while ensuring delivery of high-quality cancer care and outreach to our communities?

The answer was leadership and teamwork — combined with a bold vision that has unified our VCU enterprise, that a future without cancer IS possible. We knew that to create that future, we must build trust in our communities. Our team’s unique ability and focus on listening to and partnering with underserved communities has been a catalyst for the center’s success. Every day I see the team demonstrating VCU’s core values — like accountability, integrity and service — through this work.

We have a long way to go — cancer remains the second leading cause of death in the commonwealth. But every day, our researchers and clinician-scientists work tirelessly to find better ways to understand, prevent, detect, control and treat cancer. The center is fostering the next generation of cancer-focused oncologists and researchers. Community outreach and engagement initiatives have helped build trust in communities once disenfranchised from medical institutions.

We didn’t get here alone. I recognize not only our VCU Massey leadership, but leaders across the enterprise and commonwealth. Our colleagues at the University, VCU Health, the Children’s Hospital of Richmond, and the unwavering support from government and legislative officials, have been paramount to these efforts. To our volunteer leaders and donors, a future without cancer truly began with you — your hard work and inspiration drove us all to believe. To our faculty, staff and students that see the fruits of these labors day in and day out, I extend our utmost appreciation.

VCU Massey is proudly the 54th Comprehensive Cancer Center in the country, and it happened because of tremendous strategic work and decades of foundation building. It happened because Winn has been able to build on that foundation, and articulate Massey’s impact and hone our research focus while bringing his unique brand of joy, enthusiasm and leadership. It happened because of Massey Nation, and I for one can’t wait to see what else we will accomplish together.

Michael Rao, Ph.D. President, VCU and VCU Health System

Robert A. Winn, M.D., Michael Rao, Ph.D., and Secretary John Littel, Health and Human Resources (VA) at the comprehensive announcement event.

Message from the director Annual Report 2021-2022 Published by VCU Massey Comprehensive Cancer Center Communications Office Editor David Oglethorpe Associate editors Grace Hummel Katherine Layton Contributors Blake Belden Annie Harris Design Terri Curtis Photography VCU University Marketing Phil Newsome

A future without cancer is more than a motto at VCU Massey Comprehensive Cancer Center. Taking intentional steps to make it a reality is our commitment to every individual we serve. It has been gratifying to witness how far this team has come in reducing the cancer burden just since I joined Massey as director in 2019.

The timeframe of this report is unprecedented; it spans our progression from the peak of the coronavirus pandemic to our emergence from it. Though COVID-19 impacted many aspects of normal life, it did not stop cancer, and it certainly did not stop our work at Massey. In fact, we accelerated our efforts with the adoption of the 2021 - 2025 Strategic Plan including a new mission and vision, and unique “community-to-bench” approach that keeps the community at the core. Massey’s commitment to reducing the cancer burden across the 66 localities we serve has been reimagined to ensure our work continuously moves us towards closing cancer inequity gaps.

This starts with incorporating community voices into our research and in turn developing effective communication channels to disseminate key findings to the community. We enable community members to guide our research while we explore the intersectionality of science and social drivers in the laboratory and in the community. Our research, including clinical trials, contributes to discoveries that save and improve the lives of people across the commonwealth. Our role in shaping the next generation of diverse scientists and clinicians is also expanding as we optimize our training pathway programs to best meet the evolving needs of the cancer workforce.

As you will see in the following pages, Massey is a cancer center unlike any other. Through care and survivorship programs, Massey addresses the growing population who live beyond a cancer diagnosis. A new cancer service line will enhance our ability to do so even further, ensuring alignment across the institution and health system.

This is all made possible with the support of our donors, allowing us to address Massey’s most pressing needs and to recruit the best and brightest in the field of oncology. The initiatives funded in the past two years truly redefine what a 21st century cancer center can and should be, with community as the focus.

I am inspired by our community’s resilience and the response of our physician-scientists to advance cancer research in a direction tailored to the needs of our community. I am equally as inspired by the regional, national and global attention Massey receives for our approach to the pursuit of health equity through bi-directional education and increased access to screenings and cancer treatment.

Comprehensive Cancer Center

Together, we can make a future without cancer possible. One Team. One Fight.

A Cancer Center Designated by the National Cancer Institute

Robert A. Winn, M.D. Director and Lipman Chair in Oncology, VCU Massey Comprehensive Cancer Center Senior Associate Dean for Cancer Innovation, VCU School of Medicine

Features 8 Core values & strategic priorities

The center’s unique community-to-bench approach is designed to address Massey’s strategic priorities driven by community needs and factors contributing to the cancer burden.

10 By the numbers 12 The Lawrence legacy 14 Care & survivorship

Cancer survivorship rates are rising considerably, creating a growing need to understand and address survivors’ unique health risks and needs. Massey is reimagining a future without cancer through increased care coordination and access to state-of-the-art facilities and technology.

20 Health equity, diversity & inclusion

Whether improving access to patient-centered care, examining the interplay of biological and social drivers of health in the four most common cancer types or rolling out a new plan to enhance diversity among faculty, staff and students — Massey is committed to ensuring health equity for all.

6 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

26 Community outreach & engagement

Massey’s outreach and engagement efforts promote disparities-related research, provide cancer prevention and education, enable access to cancer screening, treatment and clinical trials and advocate for public policy.

32 Research & innovation

NCI-designated Comprehensive Cancer Centers like Massey have a longstanding history of conducting research that contributes to ground-breaking discoveries and translating them into innovative approaches to prevent and treat cancer.

40 Education & training

Massey is helping shape the next generation of cancer researchers through a robust training pathway spanning all levels of learners — from high school through early-stage investigators and health care professionals.

44 Giving

Philanthropic giving is vital to fueling cancer research and patient care. Massey donors advance the center’s mission through financial contributions, hosting events and advocating for others to take action.

TABLE OF CONTENTS

| 7

Core values & strategic priorities

Mission:

Massey has a longstanding tradition of conducting research contributing to ground-breaking discoveries and translating them into innovative approaches to prevent and treat cancer. However, barriers to health care access, distrust of medical institutions, systemic racism, social structure inequities and many other social drivers of health often prevent the benefits of these discoveries from translating equitably to all.

Using a community-to-bench model, Massey strives to go beyond the traditionally unidirectional “benchto-bedside” model that only benefits those fortunate enough to reach the bedside. In doing so, we increasingly acknowledge our community as an equal expert and strategic research partner to help address the center’s strategic priorities.

To reduce the state cancer burden for all Virginians by addressing the confluence between biological, social and policy drivers through high-impact, cuttingedge research; person-centered care across the continuum, from prevention through survivorship; community integration; and training the next generation of community-centric researchers and health care professionals

Vision: To be a premier community-focused cancer center leading the nation in cancer health equity research and ensuring optimal health outcomes for all

Values: • Excellence • Teamwork • Innovation • Integrity • Compassion & Respect • Diversity & Inclusion

Catchment area by the numbers

66

12

54 of 66

4+ million

localities (47 counties and 19 independent cities)

Rural-Urban Commuting Area (RUCA) 8-9 localities

localities are designated as Medically Underserved Areas

racially, ethnically, geographically and socioeconomically diverse individuals (38% Non-White, 6% Latine)

8 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Strategic priorities

“In parts of our community, some people do not access or do not get the screenings that will save their lives. We see too many stage three and stage four cancers instead of stage one or stage two cancers. We have a tremendous opportunity to take the work that is done here and take it to the communities that do not get those services.”

SECRETARY JOHN LITTEL HEALTH AND HUMAN RESOURCES (VIRGINIA)

CORE VALUE & STRATEGIC PRIORITIES

| 9

Massey by the numbers FY22 (July 1, 2021 - June 30, 2022) PHILANTHROPY

$122.5 million

10,579 Gifts

Endowment market value Sources of philanthropic funds

$19.4 million Total new gifts and pledges

$4.8 million Unrestricted giving

• • •

51% Major & planned giving 33% Sponsored research 16% Annual giving & events

35 Major gifts

10,884 Donors

$1,780 Average gift amount

2,959

$14.6 million Restricted giving

First-time donors

FY21 (July 1, 2020-June 30, 2021): Total new gifts and pledges - $15.9 million; Endowment market value - $120.6 million; Gifts - 10,640; Major gifts - 31; Donors - 10,235; Average gift amount - $1,493; First-time donors - 2,976.

OPERATING BUDGET

$41.2 million

Operational budget sources

10 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Operational budget uses (by category)

Data as of September, 1, 2022

CANCER PATIENT CARE

18,340

25,006

122

Total cancer patients seen

Chemotherapy treatments

Bone marrow transplants

2,955

23,733

Surgical procedures

Radiation therapy treatments

RESEARCH

142

$26.8 million

Research members by program

Peer-reviewed research funding

(9% increase since 2016*)

(52% increase since 2016*)

47 Cancer Biology

51 Developmental Therapeutics

44 Cancer Prevention & Control

Data as of June, 30, 2022 *Change reflects increase since the 2016 Cancer Center Support Grant renewal

$11 million National Cancer Institute

$10.4 million Other National Institutes of Health

$5.4 million Other peer-reviewed funding

MASSEY BY THE NUMBERS

| 11

Honoring Walter Lawrence, Jr., M.D. Massey’s vision to be a premier community-focused cancer center leading the nation in cancer health equity research and ensuring optimal health outcomes for all is deep rooted in our history. In fact, it was largely inspired by Massey’s founding director, Walter Lawrence, Jr., M.D. Throughout his life and career, Lawrence fought for social justice and health equity, tirelessly advocating for inclusivity in the medical workforce and championing the increased enrollment of minority patients in clinical trials. Lawrence passed away at the age of 96 in November of 2021, but his legacy remains a constant reminder of the center’s history and the foundation for which it was built upon.

12 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

“The real mark Dr. Lawrence leaves behind is the mission to help those less fortunate than ourselves and to ensure that health and cancer burdens are not carried more heavily by some.

And he never rested in this mission — it’s one that drives us as we fight every day.”

ROBERT A. WINN, M.D.

(Above, left to right) Portrait of former and current Massey directors, I. David Goldman, M.D., Robert A. Winn, M.D., Gordon Ginder, M.D., and Dr. Lawrence. (Below, left to right) Dr. Lawrence in Korea 1952, Dr. Lawrence MASH 1953, and Dr. Lawrence with daughter Liz Wallingford.

Born in Chicago in 1925, Lawrence’s father was a primary care physician, inspiring his own career in medicine. He attended Dartmouth College and then medical school at the University of Chicago during World War II. Following his residency at Johns Hopkins, he completed additional training at Memorial Sloan Kettering Cancer Center, where he went on to perform New York City’s first-ever kidney transplant.

Lawrence served in the U.S. Naval Reserve from 1942-1946 and later served as the chief of surgery for the 46th Army Surgical Hospital in Korea during his time in the U.S. Army from 1952-1954.

In 1966, Lawrence was recruited to VCU — formerly known as the Medical College of Virginia — to lead a new Division of Surgical Oncology, the first division of its kind. In 1974, he became the founding director of Massey, and a year later, led the center to its initial NCI designation. Lawrence served as director of the center for 14 years.

In honor of his astounding contributions to the field of surgical oncology and cancer research and care at Massey, the “Walter Lawrence, Jr., Distinguished Professorship in Oncology” was formally established by the Massey Family Foundation in 1989.

Lawrence’s work and passion also inspired decades of philanthropic support — which lives on through Massey’s Lawrence Society by recognizing donors who commit to supporting Massey’s mission through planned giving.

“Our conversations with Dad made it clear how passionate and totally committed he was to advancing cancer treatment and patient care through the establishment and development of Massey,” said Dr. Lawrence’s daughter Liz Wallingford. “We’re so honored and proud to know that part of his legacy lives on through the outstanding work that’s done in the cancer center every day.”

“He was a role model that we all aspire to as cancer center directors. To be thoughtful, wise, kind, know how to support others,and get the most out of their efforts. That’s the type of person he always was, he took his patients and his research so seriously, but he never took himself seriously.”

GORDON GINDER, M.D. FORMER MASSEY DIRECTOR AND MASSEY CLUB ENDOWED CHAIR

Gordon Ginder, M.D., Becky Massey and Dr. Lawrence (left to right)

In addition to a career of medical excellence, Lawrence served in prominent leadership roles for the American Cancer Society, Society of Surgical Oncology, Halsted Society, American College of Surgeons’ Commission on Cancer and NCI Surgical Oncology Research Development Subcommittee. He was given a Life Achievement in Science Award by the Science Museum of Virginia in 2002, and he was selected as the 2020 Honorary Member of the American Society for Radiation Oncology.

His passion for medicine and clinical innovation never waned over eight decades — Lawrence continued to treat patients and mentor students into his 90s — and he always considered it a privilege to be able to offer medical help to those in need.

“Nothing is more fulfilling than the gratitude of another human being for your professional help, and I can assure you that if you do choose medicine, this satisfaction you will feel for medical practice will never disappoint,” Lawrence wrote in an open letter to aspiring doctors in the Richmond Times-Dispatch.

“For the Massey family, we saw Dr. Lawrence as the backbone of the center. He inspired our family to engage in financial and active volunteerism from its founding in 1974.”

BECKY MASSEY MASSEY ADVISORY BOARD MEMBER

Under the tenure of Massey director Robert A. Winn, M.D., the center established an annual center-wide research retreat recognizing the innovative research being conducted by Massey scientists, students and trainees while promoting collaboration across disciplines. Massey also launched the Walter Lawrence Scholars Initiative for diverse individuals interested in science writing and cancer communications.

Lawrence will continue to be an inspiration to everyone at Massey and VCU Health, where his footsteps left an indelible path toward a future without cancer.

Learn more about Dr. Lawrence’s legacy at vcumassey.org/drlawrence

THE LAWRENCE LEGACY

| 13

“This is probably one of the most important investments that any donor could make in any Virginia institution. Because we’ve created a patient-centric model that will be duplicated — the experience will be second to none.”

MICHAEL RAO, PH.D. PRESIDENT, VCU AND VCU HEALTH SYSTEM

Experience the impact at vcumassey.org/aop

14 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Elevating cancer care At the heart of VCU Health’s new Adult Outpatient Pavilion is its world-class cancer facility. Designed as a single point of outpatient care, the new location offers improved access to screening, imaging, treatment and survivorship services to meet the needs of patients wherever they may be in their cancer journey.

VCU Health celebrated a major milestone in late 2021 with the opening of the Adult Outpatient Pavilion. The facility includes medical, surgical and radiation oncology clinics with shared spaces that support Massey’s multidisciplinary, collaborative teams in delivering seamless, well-coordinated care. The facility also houses the Cancer Survivorship Program and an infusion treatment floor that doubled the available number of infusion chairs.

To further align cancer care and other strategic Massey initiatives, the center announced the launch of its first cancer service line in 2022. The collaborative model will ensure close alignment with the health system and increase support for clinicians and staff while expanding clinical research capabilities. Massey welcomed Paula M. Fracasso, M.D., Ph.D., FACP, as the deputy director and senior vice president of the cancer service line at VCU Health to oversee strategic planning and implementation of the new service line.

“Massey is strengthened by our deep connections to the health system and the university, and streamlining those resources through the cancer service line will enable all of us to more effectively deliver high-quality care to our patients,” Fracasso says.

In addition, the facility includes leading-edge technology like the MRI-guided linear accelerator, a treatment option for patients with difficult-to-treat solid tumors, including prostate, lung, pancreas and liver tumors. The first in the region to offer this technology, Massey providers can direct radiation at cancers with even more pinpoint accuracy, sparing nearby healthy tissue and organs.

The MRI-LINAC suite was named and dedicated by TowneBank through a $150,000 grant matched through The Cabell Foundation.

Massey was also the first in Virginia to use a new FDA-approved dye called Magtrace that allows surgeons to spare the lymph nodes in the vast majority of early-stage breast cancer patients. Injected before performing a mastectomy, the dye stays in the lymph nodes longer, giving surgeons time to determine whether the cancer is invasive and helps guide a biopsy if necessary. This technological advance reduces patients’ risk of developing lymphedema — a complication where fluid painfully and conspicuously accumulates in the arm — months or years later.

CARE & SURVIVORSHIP

| 15

GIVING SPOTLIGHT

Soaring to new heights with the help of generous donors At 17 stories, the Adult Outpatient Pavilion is bringing cancer care to new heights. Helping to fuel that innovation were two community foundations — The Mary Morton Parsons Foundation and The Cabell Foundation — who committed a combined $1.25 million in a matching gift challenge to support the new oncology clinic. More than 300 unique donors collectively contributed $7 million, including gifts to name over 60 spaces.

DONOR SPOTLIGHT

A Loving gift Christiane and Larry Loving wanted to bring hope and comfort to those fighting cancer at Massey. They’d seen their own children, Noëlle and Philip Loving, lose their lives to brain cancer within three years of each other. In their honor, the Loving family — together with the Noëlle C. Loving “But Tomorrow” Foundation — donated $200,000 to name the family lounge in the Adult Outpatient Pavilion.

The Noëlle C. Loving and Philip Loving “But Tomorrow” Foundation Family Lounge, which is located on the oncology infusion floor, provides a comfortable and quiet space for patients and their families to rest and recharge between treatments. “The light in this new building is a pathway of hope,” said Larry Loving. “Where you receive treatment is important.

With the new building, the place will finally reflect the quality of the research and care at Massey, and that’s pretty exciting to be a part of.”

Larry and Christiane Loving in the Noëlle C. Loving and Philip Loving “But Tomorrow” Foundation Family Lounge.

16 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Thriving throughout cancer treatment — and beyond Massey’s survivorship model supports patients and their caregivers from the time of diagnosis through treatment.

In 2021, Massey launched a new program with a holistic, multidisciplinary approach to cancer care during and after treatment. The Cancer Survivorship Program is led

by Susan Hong, M.D., M.P.H., FACP, who was recruited to Massey in 2021 and holds the RGC Professorship in Cancer Research. Coordination of care, patient education and research activities help to address the physical and mental health effects associated with cancer treatment.

The program’s clinical arm emphasizes prevention and risk reduction for recurrent and new cancers, management of chronic health conditions such as diabetes and hypertension that increase mortality risk, and patient empowerment. Located in VCU Health’s new Adult Outpatient Pavilion, patients have access to genetic testing and counseling, dietitian services and multidisciplinary care — including services like cardio-oncology and physical, occupational and speech therapy.

“Massey’s survivorship program really helps treat my symptoms of cancer that aren’t cancer.”

TIFFANY STOUT OVARIAN CANCER SURVIVOR

Tiffany Stout (left) and Susan Hong, M.D. (right)

CARE & SURVIVORSHIP

| 17

As an emerging national leader in survivorship research, Massey is ideally situated to improve the quality of life of cancer patients, longterm survivors and caregivers through transdisciplinary science that spans preclinical to clinical research.

Oxana G. Palesh, Ph.D., M.P.H., joined Massey in 2022 with a focus on survivorship. She is currently examining the impacts of fatigue and insomnia, which affect about 80% of people diagnosed with or undergoing treatment for cancer. Palesh also holds the Massey Cancer Center Chair in Cancer Research.

Other researchers are focused on the physical side effects associated with cancer treatment. M. Imad Damaj, Ph.D., and David A. Gewirtz, Ph.D., are studying nerve damage in cancer patients, a common and significant side effect of chemotherapy treatment, with funding from the National Cancer Institute.

Azeddine Atfi, Ph.D., who holds the Mary Anderson Harrison Distinguished Professorship in Cancer Research, is investigating the mechanisms of cancer cachexia, or wasting syndrome. This debilitating syndrome affects the vast majority of patients with advanced cancer and accounts for nearly 30% of cancer-related deaths. While these researchers’ areas of study are wide-ranging, each is dedicated to better understanding and treating survivors’ most pressing health issues.

(Left to right) Oxana G. Palesh, Ph.D., M.P.H., M. Imad Damaj, Ph.D., David A. Gewirtz, Ph.D. and Azeddine Atfi, Ph.D.

18 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

PATIENT PROFILE

Charmica Epps Harris Being a survivor doesn’t stop when treatment does. Two years post-diagnosis of stage III colon cancer, Charmica Epps Harris maintains a cancer care regimen as a patient at Massey’s Cancer Survivorship Program.

“The scars and the wounds of colon cancer, we see as the shining stars of our survivorship.”

CHARMICA EPPS HARRIS

She knew her cancer journey was destined to help empower and advocate for others.

Since her diagnosis, Epps Harris became the director of development, board and hospital relations at Massey, work that has matched her passion with purpose. With the survivorship team on her side, she is looking toward the future. “Cancer is not the end. This is just an opportunity to breathe through this chapter, and go on with all the things that make life beautiful,” Epps Harris said.

Every year, millions of us lose someone to cancer.

At Massey, we are unrelenting in our quest to find new ways to understand, prevent, detect and treat cancer. Together, we can keep more loved ones in the picture.

Learn more at vcumassey.org/emptychairs

Small patients, big collaborations Pediatric cancers differ significantly from adult-onset cancer in how they develop, are treated and respond to therapy. Every day, Massey faculty and staff partner with Children’s Hospital of Richmond at VCU (CHoR) to find new treatments and potential cures that allow kids to get back to being kids.

CHoR draws on the expertise of hematologists, oncologists, radiation oncologists, surgeons, radiologists, pathologists, pharmacists and other cancer experts — many of whom are Massey research members — specially trained on the unique needs of young patients.

“From radiation oncology to research — our colleagues at Massey help our nationally ranked cancer program nurture the champion in every child who is fighting cancer.”

ELIAS NEUJAHR, M.H.A., M.B.A. PRESIDENT, CHILDREN’S HOSPITAL OF RICHMOND AT VCU

Kelsey Clark (left) and Madison Martin (right).

From clinic visits and imaging to infusion and surgery, the CHoR team uses a multidisciplinary approach to provide pediatric care all under one roof. CHoR is also one of only two programs in Virginia that train future pediatric cancer doctors. | 19

20 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Promoting health equity, diversity and inclusion Massey’s diversity, equity and inclusion efforts are grounded in a culture of excellence with a workforce reflective of local and national populations. The center’s dedication to safeguard diversity, equity and inclusion is supported by three foundational elements — leadership commitment, community input and continued evaluation — each of which are embedded across all Massey-led initiatives.

In alignment with the NIH’s Diversity Statement, Massey is committed to continued learning, understanding and increased awareness of best practices surrounding diversity, equity and inclusion. Massey established a formal Office of Diversity, Equity and Inclusion in 2021 to enhance inclusiveness and promote these efforts. Working closely with the Offices of Cancer Research Education & Training and Community Outreach & Engagement, Massey is focused on diversifying students and trainees, faculty and staff as well as center leadership.

HEALTH EQUITY, DIVERSITY & INCLUSION

| 21

Winn Awards Cohorts

Self-reported scholar demographics

Scholars represent institutions in 27 states (including the District of Columbia).

Scholars represent institutions in 27 states (including the District of Columbia).

22 |

SPECIALTY

75% Cancer (85) 34% 14% Immunologic Disorders (16) Male (39) Self-Reported Scholar 66% Female (75) 11Demographics % Cardiovascular Disease (13)

41% 29% 1% 29%

Female (75)

1% DO (2) 1% %DO/PhD (1) 75 Cancer (85) % 9 MD/PhD (10) Disorders (16) 14% Immunologic 89% MD (101)

DEGREE SPECIALTY

GENDE R

66%

ETHNICI TY

ETHNICI TY

African American/Black (47) 41% 29% Hispanic/Latino (33) Indian or Alaska Native (1) 1% American 34% 29 Male (39) % Other Identity (33)

11%

Cardiovascular Disease (13)

Winn Awards partners 1% DO (2) African American/Black (47) and supporters Hispanic/Latino (33) American Indian or Alaska Native (1) Other Identity (33)

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

DEGREE

GENDE R

Self-Reported Scholar Demographics

1% 9% 89%

DO/PhD (1) MD/PhD (10) MD (101)

Diversifying the oncology workforce In an effort to further diversify the oncology workforce, Massey is leading programs specifically designed for those often underrepresented in oncology-related fields.

Together, Massey and neighboring Virginia State University (VSU), a historically black college or university, secured an NCI P20 grant in 2021 that launched the Partnership for Cancer Disparities Research and Training Program. The collaborative initiative promotes the cancer research capacity at VSU and enhances the focus on cancer disparities research at both institutions.

The partnership also fosters an organized approach to training opportunities for underrepresented undergraduates and early-stage investigators at VSU through its Cancer Research Education Program. The training component welcomed its first cohort of VSU early-stage investigators in 2021. Three faculty fellows were selected for the four-year research experience and paired with Massey mentors. The undergraduate training portion kicked off in 2022 with the development of cancer disparities-focused curricula and a 10-week mentored research experience. Six VSU undergraduates participated in the summer program as part of a bench-science track at VCU or a community-health track at VSU.

DONOR SPOTLIGHT

Amy Pascucci Hanrahan Michael R. “Scucci” Pascucci was a nonsmoker who passed away in 2007 from non-small cell lung cancer at the age of 40. Fifteen years later, his wife, Amy Pascucci Hanrahan, still celebrates her late husband’s largerthan-life personality by hosting ScucciFest. The annual music festival has raised more than $250,000 for cancer research. Massey’s selection for a planning Specialized Program of Research Excellence (SPORE) grant reinforced what she already knew, Hanrahan said. “Massey is continuing to push the envelope and advance research in our fight against all cancers, not just lung cancer.”

Massey is also leading the implementation of the Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards), which was initially launched as the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program. Renamed in 2022 to recognize Massey’s director for his leadership in promoting new approaches to building trust among minority and underrepresented populations, the Winn Awards is transforming the clinical research landscape with the goal of increasing diversity in clinical trials.

“These awards offer diverse physician scientists and students career advancement and opportunities for growth that they may not have otherwise encountered.”

JOY JONES, PH.D. WINN AWARDS EXECUTIVE DIRECTOR

The program consists of the Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA) for early-stage investigators who are committed to increasing diversity in clinical trials, and the Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Pathway Program (Winn CIPP) for medical students underrepresented in medicine. The program aims to train, develop and mentor nearly 300 diverse and community-oriented clinical trialists and nearly 300 medical students by 2027.

Amy Hanrahan (right) with friends and Massey team members at the 2021 ScucciFest event.

| 23

Teaming up against lung cancer disparities Massey has been a catalyst for bringing together renowned experts through nationally funded team science initiatives to help overcome these disparities.

In 2021, Massey was awarded the commonwealth’s first National Cancer Institute (NCI) planning Specialized Program of Research Excellence (SPORE) award in collaboration with City of Hope Comprehensive Cancer Center and the USC Norris Comprehensive Cancer Center.

The award supports two initial research projects, including one led by Massey director, Robert A. Winn, M.D., Lipman Chair in Oncology, and Patrick Nana-Sinkam, M.D., Linda Grandis Blatt Endowed Chair in Cancer Research and Chair of the Division of Pulmonary Disease and Critical Care Medicine.

The pair are exploring how environmental stress, smoking and biology intersect to increase lung cancer risk. The award also fosters a pathway of new research concepts and engages community groups across Virginia and California to better understand lung cancer disparities.

As part of the Stand Up To Cancer’s Health Equity Initiative, Massey partnered with MUSC Hollings Cancer Center and UNC Lineberger Comprehensive Cancer Center to secure a $3 million award. The grant established the Southeastern Consortium for Lung Cancer Health Equity, which is partnering with local federally qualified health centers to eliminate barriers to lung cancer screening that underserved populations often face.

The consortium will also create a repository of clinical data and biospecimens from Blacks/African Americans at risk for or diagnosed with lung cancer to develop an improved clinical biomarker and increase the diversity of samples that is lacking in many existing biobanks.

More people die from lung cancer than any other cancer and some groups are more affected than others: Black men in particular have both a higher incidence and higher mortality rate than others.

NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES

24 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Alliance for Equity in Cancer Care Massey was named as the National Program Office (NPO) for the Alliance for Equity in Cancer Care, a $20 million initiative funded by the Merck Foundation. Massey’s commitment to community-based partnerships and leadership in cancer health equity research are just two of the reasons the center was selected.

The initiative has awarded funds to select nonprofit health care organizations to develop and implement strategies aimed at improving equitable, patient-centered cancer care and addressing access barriers related to social drivers of health. In collaboration with community partners, these evidence-informed programs are designed to help cancer patients living in underserved communities receive timely access to high-quality, culturally responsive care.

As NPO, Massey is assisting grantees in building collaborative partnerships and evaluating effectiveness of interventions while identifying and promoting best practices for patient navigation and care coordination.

Following the five-year program, a cross-site evaluation will be conducted by the NPO and results will be widely disseminated in an effort to advance equitable health outcomes and improve the health and wellbeing of cancer patients from vulnerable populations.

Learn more about the Alliance at equityincancercare.org

HEALTH EQUITY, DIVERSITY & INCLUSION

| 25

Dr. Leo Whitaker (center), Minister of Baptist General Convention of Virginia, shares insight with community members across the commonwealth.

26 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Building trustworthiness in research Massey has worked tirelessly to make cancer research, clinical trials and patient education more inclusive and accessible over the past two years.

Now more than ever, Massey is reaching those who have historically been disproportionately affected by cancer and other health concerns across the catchment area — with plans to expand programming for other vulnerable groups, including LGBTQIA+ and Native American communities.

Charting a path through research In 2021, nearly 800 people participated in a community discussion on trust in research, including implicit bias and its effects on certain racial or ethnic groups in regard to clinical trial participation. Led by Massey and Duke University, the event honored the life and legacy of Henrietta Lacks, who died of cervical cancer at the age of 31. Lacks’ unique cervical cancer cells were integral to global medical advances enabling the treatment or prevention of diseases such as polio, AIDS and cancer. Unfortunately, they were used without her or her family’s consent. Lacks’ great-granddaughter, Veronica Robinson, shared her perspective on her family’s experience with biomedical research as well as its impact on participation and ethics in the modern era.

COMMUNITY OUTREACH & ENGAGEMENT

| 27

Bridging faith and science in the community Within months of his appointment as Massey director, Winn recognized how misinformation surrounding the COVID-19 virus was impacting local communities. When local lawyer, Cancer Community Connection Coalition chair and Massey Advisory Board member Rudene Mercer Haynes, J.D., introduced Winn to Rev. F. Todd Gray of Fifth Street Baptist Church, the trio realized the role the faith-based community could play in debunking myths about the ever-evolving pandemic and serving as a local resource for those hit the hardest by its effects, particularly the African American community.

“Health and wellness is something we haven’t focused on enough in the faith community. I think this has a life after COVID-19 is over.”

RUDENE MERCER HAYNES, J.D.

Known now as Facts & Faith Fridays, more than 100 virtual conversations have been hosted with local, regional and national health leaders — including First Lady Jill Biden, Ed.D., and National Institute of Allergy and Infectious Diseases director, Anthony Fauci, M.D. Reaching thousands of participants, topics have ranged from social justice and masking guidelines to racial disparities in COVID-19 and cancer. Facts & Faith Fridays continues today as Massey works with city leaders and community partners to expand its reach to more vulnerable populations across the state.

DONOR SPOTLIGHT

Rudene Mercer Haynes, J.D. Rudene Mercer Haynes, J.D., is a a long-time supporter of Massey, helping launch Facts & Faith Fridays in 2020. More recently, she was named the inaugural chair of Massey’s new Cancer Community Connection Coalition, which helps inform the center’s cancer-related priority areas and support legislative initiatives and policy efforts.

But she is more than a cancer advocate, she is a cancer survivor.

Haynes’ diagnosis with breast cancer in 2022 changed her perspective on life, she said. Haynes is a partner with Hunton Andrews Kurth LLP, the wife of a pastor and mother of two. Her work with the center has been vital in bringing community voices into strategic, bi-directional conversations at Massey.

Haynes (center) is pictured with interns from the Rudene Mercer Haynes Clinical Trials Office Summer Internship.

28 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Closing the gap in cancer disparities Massey convened its inaugural Closing the Gap Summit in April of 2022, with a focus on breast cancer. More than 80 physicians, researchers and — most importantly — community members, explored critical issues related to the disease and what contributes to prevalent disparities in breast cancer incidence and mortality. The summit included a panel discussion with Massey’s Community Champions, who help promote dialogue between Massey investigators and the community. A pilot funding opportunity was announced for summit attendees who would work with a Community Champion to continue fostering engagement between physician-scientists, researchers and the community.

Massey’s Closing the Gap Summits will continue semiannually with a focus on one of the center’s four priority cancers — breast, lung, prostate and gastrointestinal cancers.

“It’s about bringing the community voice into research, but also disseminating results into the community in engaging and helpful ways.”

MARIA THOMSON, PH.D. COMMUNITY ENGAGEMENT IN RESEARCH DIRECTOR

Participants of the inaugural Breast Cancer Closing the Gap Summit join in discussions and research presentations during the April event.

COMMUNITY OUTREACH & ENGAGEMENT

| 29

Massey’s strengths are best reflected in the center’s community partnerships. The newly established Office of Community Outreach & Engagement serves as a bridge between Massey and those within the catchment area who are most in need.

Planting community-led health initiatives

Partnering to improve cancer screening access

In 2021, Massey launched its first Community Grant Initiative to enable local organizations to improve health outcomes in their communities. Supported in part through unrestricted gifts from generous donors, the grant provided seven Virginia-based organizations with $5,000 seed grants to support wellness priorities identified by and for their respective communities. Initiatives included cancer prevention and education services, referral assistance and resources for patients and caregivers. Massey launched the second round of seed grants in late 2022.

In the wake of the COVID-19 pandemic, routine cancer screenings have drastically declined. Project COALESCE is working to increase access to colon and cervical cancer screening and diagnostic follow-up. The project connects federally qualified health centers and health care organizations in Virginia with non-clinical partners to better address structural barriers — like homelessness or lack of insurance — to screening services. By leveraging organizations that already have strong ties to vulnerable populations, COALESCE hopes to promote cancer screening awareness in addition to increasing screening rates. Led by Katherine Tossas, Ph.D., M.S., a Harrison Endowed Scholar and director of Massey’s catchment area data access and alignment, COALESCE launched in early 2021 with funding from Pfizer Global Medical Grants and oversight by the American Cancer Society.

30 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Conquering Addiction to Nicotine: Massey CAN Smoking is linked to more than 10 different types of cancer, not just lung cancer. But it is notable that for lung cancer patients between the ages of 20 to 64, half continue to smoke, according to the American Cancer Society. In response, Massey’s free community-based tobacco cessation program, We CAN Quit, connects smokers with ‘quit coaches’ and other support resources. The program works with both individual community members and partnering organizations. Since its inception in 2022, the program has provided 74 one-on-one quit coaching sessions for 30 individual participants. Massey also partners with local organizations and the VDH Tobacco Control Program to educate hundreds of Virginians on the risks of tobacco use and the substantial health and financial benefits of tobacco cessation.

To learn more about the We CAN Quit program, visit vcumassey.org/wecanquit

GIVING SPOTLIGHT

Massey on the Move Two Massey on the Move mobile health vans funded through corporate and foundation grants will take to the streets in 2023 to provide critical cancer education and outreach throughout Massey’s catchment area. Through its Social Justice Grants Initiative, which seeks to address systemic inequity and health disparities, Dominion Energy Charitable Foundation awarded Massey a $300,000 grant to help fund the vans. Educational materials promoting healthy living and cancer screenings are supported through a $150,000 grant from Bank of America, awarded to Massey as part of a $1.25 billion commitment to advance racial equality and economic opportunities nationwide.

Additional support was provided by the Jenkins Foundation and the Shelton Hardaway Short, Jr., Trust.

Artwork for the Massey on the Move vans is the result of a collaboration between Massey and two Richmondarea community artists, Sir James Thornhill (above) and Hamilton Glass (below).

COMMUNITY OUTREACH & ENGAGEMENT

| 31

Paula D. Bos, Ph.D., and colleague in the research laboratory at Massey.

32 | MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

An unwavering commitment to cancer research Every day, Massey researchers are working to eliminate the burden of cancer and improve survivorship for all. Nearly 150 research members are developing innovative approaches to better understand, prevent, detect and treat cancer.

Research priorities include lung, breast, prostate and gastrointestinal cancers as well as significant behavioral factors driving the cancer burden like tobacco use and obesity control.

RESEARCH & INNOVATION

| 33

Understanding diet and obesity as a cancer risk factor Through a study funded by the National Cancer Institute (NCI), Sarah Spiegel, Ph.D., and Chris Green, Ph.D., identified a specific gene that supports the growth of liver cancer in tandem with obesity and diabetes in men. By targeting and deleting the SphK2 gene in males with a highfat and sugary diet, the scientists were able to suppress the development of hepatocellular carcinoma, the most common form of liver cancer. Diabetes and obesity are significant health issues in Massey’s catchment area and this study could inform novel treatment options for disease associated with these conditions. Spiegel was named among the top 100 female scientists in the US for 2022 by Research.com.

Several new research members are identifying biological, behavioral and social drivers that contribute to cancer risk, particularly among diverse populations. Recruited in 2022, Victoria J. Findlay, Ph.D., and David Turner, Ph.D., study the negative links between harmful compounds in highly-

34 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

processed foods, mammary gland development and the development of chronic disease. The two are examining lifestyle-associated reactive metabolites as a risk for breast cancer with funding from the NCI. Massey researchers also develop and test community health promotion interventions. The Wellness Engagement Project, led by Jessica LaRose, Ph.D., and Maghboeba Mosavel, Ph.D., is evaluating the effectiveness of a community-based partnership to address the influences of social, cultural, economic and individual factors on obesity, a known driver of multiple cancer types. Informed by community input, the intervention aims to increase physical activity and improve nutritional choices among local residents.

Addressing breast cancer growth and metastasis In 2022, an estimated 7,600 women were diagnosed with breast cancer in the commonwealth, but many immunotherapies have had limited success in treating aggressive forms of the disease. Through a first-of-its-kind study, Paula D. Bos, Ph.D., and Mikhail Dozmorov, Ph.D., uncovered a previously unknown function of a type of immune cells called regulatory T cells. The cells act as a major driver of breast cancer growth by controlling the balance between pro- and anti-tumor responses.

Through a genomic screening method known as CRISPR/CAS9 screening, Anthony C. Faber, Ph.D., and Jennifer Koblinski, Ph.D., identified a specific enzyme called UBA1 as an ideal therapeutic target in triple-negative breast cancer (TNBC). TNBC is an aggressive form of disease with limited treatment options. Using a novel drug (TAK-243) that blocks the function of this enzyme, they effectively killed breast cancer cells. Their study, which was recently published in PNAS Nexus, is the first to suggest that UBA1 inhibitors could be effective in TNBC. TAK-243 has been tested recently in early phase trials, paving the way for potential testing in TNBC patients.

DONOR SPOTLIGHT

Laura Lee & Ted Chandler In 2022, Massey donors Laura Lee and Ted Chandler toured the research laboratory of Paula D. Bos, Ph.D., and Priscilla Hwang, Ph.D., to see collaborative research at work.

The experience led the Chandlers to make a $50,000 gift to the Chandler Family Research Project Fund, which supports collaborative research projects. Bos and Hwang are exploring breast cancer metastasis and how the immune system (Treg cells) and the extracellular matrix of tumors interact to promote or inhibit metastasis.

RESEARCH RECOGNITION

2022 AACR annual conference Each year, thousands of experts convene at the American Association for Cancer Research annual meeting to highlight advances in cancer research. A wide array of Massey’s cutting-edge scientific findings and achievements were on display at the 2022 annual meeting in New Orleans.

At the event, Massey director Robert A. Winn, M.D., was recognized nationally for his contributions to increase diversity in the field of cancer research. The Bristol Myers Squibb Foundation, together with its partners, National Medical Fellowships and the AACR, announced a new name for the $100 million, five-year initiative they launched in 2020 to increase diversity in clinical trials: The Robert A. Winn Diversity in Clinical Trials Award Program. Winn was also honored with the AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship.

Nearly 30 faculty members and VCU trainees represented the center, several who served as session chairs, panelists and subject matter experts. Massey also showcased nine scientific abstracts that included more than 20 collaborators across Massey and VCU. The center’s presence at the event highlighted research across a variety of disciplines and disease types.

2022 AACR NEXTGEN STAR

Katherine Y. Tossas, Ph.D. In 2022, Katherine Y. Tossas, Ph.D., was named as an AACR NextGen Star., which helps increase the visibility of early-career scientists through professional development opportunities. During the 2022 annual meeting, Tossas presented her research on the vaginal microbiome and risk of precervical cancer among different races. Just a year prior, she received the AACR Minority Faculty Scholar Award. | 35

Leveraging Massey discoveries through Molecules to Medicine Increasing access to new therapies and clinical trials for early-phase treatments is a key part of informing tomorrow’s cancer treatments. Massey’s Molecules to Medicine initiative promotes the discovery of cancer fighting drugs and biologics (molecules) by Massey basic scientists and strengthens collaborations between basic and clinical researchers to translate these laboratory molecules to bedside medicines.

Paul Fisher, M.P.H., Ph.D., FNAI, and his collaborators Devanand Sarkar, M.B.B.S, Ph.D., and Xiang-Yang “Shawn” Wang, Ph.D., are developing the next generation of cancer-targeting viral therapies. Understanding how difficult cancer cells are to target effectively, Fisher and colleagues engineered a two-part cancer terminator virus that can selectively target and destroy tumor cells without harming healthy cells. They also designed an innovative delivery method that protects the virus from being identified and targeted by the body’s natural immune response before it can attack the cancer cells. The cross-campus collaboration has shown early success in a variety of cancer types with plans to implement clinical trials to test this novel treatment strategy in patients.

36 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

“It is imperative that we seamlessly translate our own laboratory discoveries into clinical trials and extend their impact to the community.”

SAÏD SEBTI, PH.D. ASSOCIATE DIRECTOR FOR BASIC RESEARCH AND LACY FAMILY CHAIR IN CANCER RESEARCH

DONOR SPOTLIGHT

Karen & Peter Shudtz A $1.5 million gift from Karen and Peter Shudtz in 2022 — matched through VCU’s Glasgow Incentive — created the Georfrey R. Shudtz Chair in Pancreatic Cancer Research. The gift honors their late son, Geoff, who died from pancreatic cancer in 2019 less than a year after becoming a new dad. Despite his illness, Geoff lived his life by a doctrine of positivity, adopting a motto for himself and the family that spurred the creation of the Fight Cancer Stay Positive Foundation to raise money for pancreatic cancer research.

Pancreatic cancer has just a 10 percent survival rate over five years. The disease also happens to have less funding compared to other cancers like breast and lung.

Jose G.Trevino, M.D., FACS

Supporting excellence in pancreatic cancer research and care

Peter and Karen Shudtz with their son Geoff, his wife Julie, and grandson Emery.

Physician-scientists at Massey aren’t just conducting pancreatic cancer research, they are ensuring all patients have equal access to the leading-edge treatment options offered through clinical trials. In recent findings published in the Journal of Clinical Oncology, a group of researchers — including Jose G. Trevino, M.D., FACS, Massey surgeon-in-chief and chair of the Division of Surgical Oncology at the VCU School of Medicine — determined that traditional eligibility requirements for clinical trial enrollment disproportionately prevent Black patients from participating in pancreatic cancer clinical trials. The study argues that revising the standard criteria for clinical trial enrollment could have a profound effect on increasing eligibility and participation of underserved populations.

“It is overwhelming to think that Geoff’s story will be shared forever in the name of pancreatic cancer research and advocacy.”

JULIE SHUDTZ WIFE, GEOFF SHUDTZ RESEARCH & INNOVATION

| 37

A future without cancer starts with clinical trials Through one of the largest selections of clinical trial offerings in Virginia, Massey is leading new approaches that will help shape the standard of care tomorrow — and clinical trial participants like Linda Ray are helping make it happen. A pastor at Chamberlayne Heights United Methodist Church, Ray saw her participation in a trial as ‘part of the bigger picture’ following her diagnosis with triple-negative breast cancer in late 2020.

“That service, that sense of giving back, that’s something that you have power over.”

LINDA RAY BREAST CANCER SURVIVOR

Linda Ray

An upward trajectory Behind the scenes is a team of experts that are making it possible for patients like Ray to participate in clinical trials at Massey. With philanthropic donations and investments, the center has overhauled its clinical research infrastructure in the last two years — doubling the workforce and enhancing the expertise of its Clinical Trials Office staff. Reorganization of its operational functions into specialized units has helped to maximize capabilities and efficiency. In addition to the recruitment of highly experienced leaders, these changes laid the groundwork for Massey to continue its upward trajectory and reach a record-high number of patients accrued on clinical trials in 2022. “When standard treatments may not work, clinical trials can offer hope and new opportunities you wouldn’t get access to otherwise,” Andrew S. Poklepovic, M.D., associate director for clinical research says.

Under the leadership of Harry D. Bear, M.D., Ph.D., who served as associate director for clinical research during Massey’s recent Cancer Center Support Grant renewal, the center experienced a 33% increase in interventional treatment accruals.

38 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

GIVING SPOTLIGHT

Women and Wellness Generating awareness and funding for clinical research remains a top philanthropic priority for Massey. It’s the spark needed to move innovative scientific ideas and community-focused initiatives from the clinic to the bedside and beyond.

Women and Wellness has empowered women in the fight against cancer for nearly three decades, raising over $5 million for research and care for women’s cancers. For the 2022 event, the volunteer committee launched the Women and Wellness Clinical Trials Initiative to highlight female researchers and physicians at Massey who are conducting clinical research on women’s cancers.

Leslie M. Randall, M.D., with patient

Enhancing clinical trial opportunities for every patient Despite a growing portfolio of clinical trial offerings, ethnic and racial minorities remain disproportionately underrepresented in clinical research. Through its Minority/Underserved NCI Community Oncology Research Program (MUNCORP), Massey is helping patients, particularly minority and underserved individuals, access community-based clinical trials close to home. The clinical research network partners with health systems and oncology medical practices statewide. The center is one of only 14 MU-NCORPs in the country and recently earned a Gold Certificate of Excellence from the NCI for high accrual between August 2021 and July 2022.

“We are advancing the standard of care at lightning speed — and it’s all due to clinical trials.”

LESLIE M. RANDALL, M.D. CLINICAL TRIALS OFFICE MEDICAL DIRECTOR, GYNECOLOGIC ONCOLOGY DIRECTOR AND THE DIANNE WRIGHT PROFESSOR FOR OB-GYN ONCOLOGY RESEARCH

Funds raised have helped support clinical trials for women’s cancers, expand integrative health and survivorship programs and increase access to high-quality cancer care for all women.

Learn more at vcumassey.org/womenandwellness

| 39

Bryan McKiver (front) in the laboratory with mentors Devanand Sarkar, M.B.B.S., Ph.D. (left), and David A. Gewirtz, Ph.D. (right)

40 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Training the next generation of cancer researchers In addition to underserved and minority-focused training programs, Massey fosters career development and research opportunities for students at the high school level to early-stage investigators and health professionals. These efforts are coordinated through Massey’s new Office of Cancer Research Training & Education, led by Devanand Sarkar, M.B.B.S., Ph.D., associate director for research training and education and Harrison Foundation Distinguished Professor in Cancer Research.

Longstanding initiatives like the NCI-funded T32 training program in Cancer Prevention and Control and Cancer Health Equity and the American Cancer Society (ACS) Institutional Research Grant have been critical as Massey expands its research training pathway.

The Cancer Prevention and Control and Cancer Health Equity training program for graduates and postdoctoral trainees is led by Bernard F. Fuemmeler, Ph.D., M.P.H., and Vanessa B. Sheppard, Ph.D., and has been continuously funded for more than 10 years. Fuemmeler serves as Massey’s associate director for population sciences and holds the Gordon D. Ginder M.D. Chair in Cancer Research; and Sheppard is the interim associate director for community outreach and engagement and Theresa A. Thomas Memorial Foundation Chair in Cancer Prevention and Control.

.

Trainees partake in a mentored research experience focused on cancer prevention and control and cancer health equity science. Bryan McKiver is one of many who have experienced success through the program. McKiver is actively working with Massey investigators exploring molecules regulating chemotherapy-induced pain.

“This is a really important award because it’s the only award at Massey that’s entirely dedicated to supporting early-stage investigators.”

ANITA HARRISON, M.P.A. EXECUTIVE DIRECTOR FOR RESEARCH STRATEGY

Massey is also shaping the careers of its early-stage investigators through a variety of funding opportunities. The ACS Institutional Research Grant, led by David A. Gewirtz, Ph.D., has been continuously funded for nearly five decades. The grant enables Massey to allocate pilot research funding to cancer researchers to generate pilot data, which can then be used to apply for extramurally funded grants, such as an R01. The ACS grant was renewed in 2021 and has supported dozens of earlystage investigators since its initial award.

Learn more about the ACS Institutional Research Grant at vcumassey.org/acs

EDUCATION & TRAINING

| 41

Cancer Research Training Spotlights Summer Healthcare Experience in Oncology In 2022, Massey launched the Summer Healthcare Experience in Oncology Program, sponsored by the American Cancer Society. SHE is specifically designed for Virginia high school students who identify as female and are underrepresented in the sciences as an introduction to the career and leadership opportunities in oncology. The two-week program provides virtual experiences including at-home laboratory experiments, professional development workshops and panel discussions with research and medical professionals across the U.S. Since its inception, 14 students have participated in the SHE program.

“As a participant in the Rudene Mercer Haynes CTOSI, I was not only able to build my knowledge, improve my interpersonal skills and expand my personal network, but I was also able to partake in meaningful, patient-centered clinical trial activities. My experiences from this internship have helped define my career goal of pursuing both medicine and cancer research.”

SERA LIM (VCU HONORS COLLEGE) BIOLOGY MAJOR, CHEMISTRY MINOR

Learn more about the program’s namesake, Rudene Mercer Haynes J.D.; on page 28.

James D. Popp Student Research Fellowship

2022 SHE participant Illana Castro conducts an experiment with an at-home lab kit.

Rudene Mercer Haynes Clinical Trials Office Summer Internship Harry D. Bear, M.D., Ph.D., pictured with 2022 Popp fellow Carolyn Haynes.

2022 interns from the Clinical Trials Office Summer Internship and Walter Lawrence Scholars Initiative are pictured at Massey with Robert A. Winn, M.D., and CTO staff.

The Rudene Mercer Haynes Clinical Trials Office Summer Internship was also established in 2022 and offers a pathway for exploration into clinical research. Through the internship, participants not only gain insight into clinical trial careers pathways, they are also exposed to clinical trial operations at an NCI-designated Comprehensive Cancer Center. The internship is geared towards rising juniors and seniors in college, particularly those from underrepresented populations, interested in biomedical research.

42 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Originally established in 2010, the James D. Popp Student Research Fellowship encourages first-year medical students at VCU to engage in cancer-related research during the summer following their first year of medical school. The eight-week summer training program pairs fellows with a research scientist at Massey, offering first-hand research and laboratory-based learning opportunities at an NCI-designated Comprehensive Cancer Center. Fellows also benefit from networking and career development activities through attendance at nationallevel conferences and participation in VCU and Massey-led educational events. Since 2010, more than a dozen fellows have been supported through the James D. Popp Student Research Fellowship.

Learn more about the Popp Fellowship at vcumassey.org/jimpopp

DONOR SPOTLIGHT

Jack Harr, Ph.D. In the summer of 2008, Jack L. Haar, Ph.D., a Professor of Anatomy at VCU at the time, and his son Philip went on a TransAmerica fundraising bicycle ride. The ride was in support of Jim Popp, M.D., a caring physician, devoted husband and loving father of five children, who died of cancer at the age of 45 in 2007. Jim worked in the laboratory of Dr. Haar at VCU prior to and during the years he was a medical student in the 1980’s. The James D. Popp Student Research Fund was established and the annual Ride For Jim dedicated to the memory of Jim Popp and his fight against cancer.

Although the Ride For Jim is no longer active, the fund remains open and gratefully accepts contributions in support of the James D. Popp Student Research Fellowship.

Jack L. Haar, Ph.D., pictured with former Popp fellow Stephanie DeMasi.

We owe our Comprehensive designation to Team Massey’s UNRELENTING dedication and hard work.

Learn more on page 48. | 43

The power of philanthropy Philanthropic giving fuels research and innovation in cancer care. In FY22, more than 10,000 Massey donors contributed a record $19.4 million to power the center’s mission forward.

VCU President Michael Rao, Ph.D. (right) speaking with Advisory Board and Massey Club members.

Giving impact Philanthropic giving enables Massey to:

Endowments & professorships

• Conduct clinical research and increase clinical trials access to bring the latest cancer treatments to patients.

• Provide seed funding to advance promising research projects that are traditionally underfunded.

Gifts that create endowments and fund professorships are a critical tool to help Massey advance our research priorities and to recruit and retain the best and brightest minds, building Massey’s reputation as a center of excellence.

• Expand education about cancer prevention and screenings to communities across Virginia.

Planned giving

• Equip our researchers with the latest technologies and resources needed to advance scientific discoveries.

• Recruit and retain top physicians and researchers.

WAYS TO GIVE

Gifts made through estate planning create a legacy by investing in research. “When you establish a planned or endowed gift, you create a permanent legacy of support,” said Margaret Ann Bollmeier, MCV Foundation president and CEO.

Massey Club & annual giving

Corporate & foundation support

Massey Club and annual giving provide unrestricted funds to advance the center’s research priorities like clinical trials, faculty recruitment and pilot funding for novel research ideas that have the potential for significant impact.

Massey’s corporate champions are passionate leaders in the community who share Massey’s vision for a future without cancer. Corporate gifts and sponsorships grew by 36% in FY22 to $1.6 million with nearly 80 corporate champions backing Massey’s mission.

Major & restricted giving Gifts of $50,000 or more are high-impact ways to drive innovation and new discoveries in cancer research and may be specified toward a certain cancer or research need.

44 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Matching gifts Double the impact of your gift by participating in your company’s matching gift program.

5P Foundation advances clinical trials

GIVING SPOTLIGHTS

VCU Giving Day VCU’s inaugural Giving Day on April 28, 2022, raised $2.5 million from nearly 5,000 total gifts — that included $130,000 for Massey to advance clinical trials, wellness education and cancer health equity. A matching gift challenge from Massey Advisory Board’s Ellen Bonbright boosted the total along with $10,000 earned in challenge grants.

Massey Club Thirty years ago, a group of Massey donors created something extraordinary. Massey Club is the center’s leadership annual giving society, which recognizes committed supporters who make annual unrestricted gifts totaling $1,000 or more.

“Unrestricted funding raised by Massey Club is critical. Grants can sometimes take years to obtain but having that flexibility through unrestricted donations enables Massey to move things ahead faster and realize important scientific advances that otherwise could be lost,” said Gordon D. Ginder, M.D., former Massey director and Massey Club Endowed Chair.

Massey Club funding allows our scientists to focus on research as they pursue innovative ideas and new approaches.

In FY22, a gift from the 5P Foundation gift established two funds at Massey to advance cancer research and access to clinical trials that address cancer health disparities. The gift was matched through VCU’s Glasgow Incentive.

DONOR SPOTLIGHTS

Judy & Harry Wason Advances in immunotherapy at Massey inspired Judy and Harry Wason to create an endowed professorship to boost immunooncology research. The Harry and Judy Wason Distinguished Professorship was awarded to Xiang-Yang “Shawn” Wang, Ph.D., whose research to develop an immunotherapeutic drug that boosts the immune defense system to effectively fend off multiple forms of cancer was recently published in the Journal for Immunotherapy of Cancer.

Dudley & Dick Luck

Massey Club by the numbers (FY22)

$1.5 million

596

Raised by Massey Club (FY21 $1.7 million)

Massey Club families donated (FY21 559)

108

$2,700

First-time donors (FY21 45)

Average gift amount (FY21 $3,034)

Learn more about ways to give at vcumassey.org/give or scan the QR code to give today.

Dick and Dudley Luck (left) on a trip to Kenya in 2019 before Dick’s cancer diagnosis.

Dudley and Richard “Dick” Luck, Ed.D.,’s experience with Massey extends back to 1976, when Dick served on an advisory council for Massey founding director Walter Lawrence, Jr., M.D. Decades later, when Luck was diagnosed with colon cancer and treated at Massey, he and his wife, Dudley, added the center as a beneficiary to a charitable remainder trust. The trust provides a lifetime income stream for the Lucks with the accumulated principal gifted to Massey at the time of death.“I have a husband because of Massey,” Dudley Luck said. “And that’s a pretty big thing.”

GIVING

| 45

Massey Highlands Golf Tournament (above) and Massey Challenge, Women and Wellness, Swim Across America Richmond (below, left to right)

Impactful gatherings In FY22, the Massey community stood strong, hosting events — from music festivals to sports tournaments — to keep our mission moving forward. The center’s signature events kept pace, providing opportunities for donors to celebrate together with the shared goal of a future without cancer.

46 |

4

31

$650,000+

Massey signature fundraising events

Community-hosted events

Raised through events

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

(FY21 $672,295)

MASSEY EVENTS

COMMUNITY EVENTS

Running toward a future without cancer

Making waves against cancer

Thirty-one teams and 190 individuals stepped up to fight cancer as part of the 17th annual Massey Challenge, held in conjunction with the Ukrop’s Monument Avenue 10K on April 23, 2022. Center director Robert A. Winn, M.D., joined top fundraising teams, St. ChristoCURES, Bust A Move, and The Beam Team to raise $128,000 for Massey.

Twenty-seven years of Women and Wellness Women and Wellness engages and empowers women in the fight against cancer. Best-selling author, Suleika Jaouad, inspired guests at the 27th annual Women and Wellness luncheon with her story of perseverance following a cancer diagnosis in her 20s and again in 2021. FY22 events included an educational conference and peer-hosted social gatherings, with support from TowneBank and Primis, to raise $180,000 for clinical trials to combat women’s cancers.

Massey Alliance keeps the fun in fundraising For the Massey Alliance, Massey’s young professional board, making a future without cancer possible includes fun with friends. In FY22, the Alliance raised $118,500 in FY22, through a series of social events. Massey on the River raised $90,000 despite being virtual with support from presenting sponsor First Citizens Bank and corporate champions Travis L. Shaw, M.D., Gumenick Properties and Apex Systems. The Alliance drove toward $14,500 at the first Massey at Belmont Golf Tournament and hosted an Appetizers & Advocacy event highlighting Massey researchers’ innovation in neuro-oncology.

The third annual Swim Across America Richmond welcomed 150 individuals who swam (or floated) one mile along the James River, some in inflatable flamingos and donning crazy wigs to show support for those undergoing cancer treatment. Each year, the event funds the research of an early-stage investigator at Massey, and in FY22, raised $50,000.

Putting a slam dunk on cancer The 14th annual Capitol Square Basketball Classic pits members of the Virginia Senate, House of Delegates, Governor’s Office and lobbyists on- and off-court to raise money to help put a slam dunk on cancer. In FY22, Team House took the win but the real winner was Massey, with $55,000 raised.

Playing it forward This ladies doubles tennis tournament hosted by Women and Wellness co-chair Tara Daudani made a racket against cancer, raising $5,000 in its first year.

5K for cancer research With support from donors Charles and Ginny Crone and Randall and Shelby Hawthorne, the William & Mary track and field and cross country teams’ 34th annual 5K in FY22 raised over $13,000.

Fighting “fore” a cure The Highlands-Massey Classic Golf Tournament hosted by Massey Board member and survivor, George Emerson, has contributed $2.8 million to fight breast and head and neck cancers since 2006. The FY22 event raised $93,000.

GIVING

| 47

A comprehensive cancer center for the 21st century Massey received comprehensive designation in 2023 ­— the highest recognition from the National Cancer Institute — reflecting our scientific leadership, depth and breadth of research, effective community outreach and cancer research training and education.

How are we influencing the new standard of care?

Advancing research and clinical trials for all through a community-to-bench model Transdisciplinary teams work with the community as a research partner to better understand, prevent, detect and treat cancer.

Training the next generation of community-centric researchers and providers Pathway programs and partnerships with minority-serving educational institutions and industry leaders support cancer disparities research training and the development of emerging scientists from diverse backgrounds across all learning levels.

Ensuring equitable access to person-centered care from prevention through survivorship In addition to promoting cancer risk reduction and prevention, patient navigators and coordinated care teams guide patients from screening through treatment options, clinical trials and supportive services such as Massey’s Cancer Survivorship Program.

Experience the impact at vcumassey.org/comprehensive or scan the QR code.

Community-centered Introducing a new generation of cancer centers — one that integrates community input into everything we do in order to close health care gaps across race, ethnicity and geography.

• Cancer Champions include community members and Massey researchers who work together to better refine scientific questions and serve as a touchpoint in the community.

• Massey serves as a leader in health equity efforts and training programs including the Robert A. Winn Diversity in Clinical Trials Award Program and the NCI Comprehensive Partnership to Advance Cancer Health Equity.

• Massey’s Stand Up to Cancer grant seeks to reduce disparities affecting Black Americans by partnering with federally qualified health centers to guide patients through lung cancer screening.

“We are leading the charge, not just in research but in building trust and breaking down barriers between medical institutions and communities. This allows us to turn research into results and deliver truly personalized care.”

ROBERT A. WINN, M.D. DIRECTOR AND LIPMAN CHAIR IN ONCOLOGY

48 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Learn more about how Massey’s designation is impacting patients, community partners and constituents across the commonwealth.

“This comprehensive designation demonstrates that we put the needs of patients and our communities first. We have taken our efforts to extraordinary levels to benefit all patients in need and the many communities we serve throughout our diverse commonwealth.”

MICHAEL RAO, PH.D. PRESIDENT, VCU AND VCU HEALTH

“We celebrate Massey’s achievement as a huge win for our entire institution, and one that will help us continue to raise the bar for excellence at VCU Health. The dedication to innovative research and education and to advancing health equity is a clear reflection of our health system’s core values.”

MARLON LEVY, M.D., FACS INTERIM SENIOR VICE PRESIDENT, VCU HEALTH SCIENCES AND CEO, VCU HEALTH

“Massey is at the forefront of research and collaboration, amplifying unique research efforts surrounding cancer disparities across the state and distinguishing itself as a pioneer for post-treatment survivorship study and treatment. Known for their dedication to cultivating a relationship between training and education among researchers and local health care professionals, the center continues to lead the charge in award winning medical care and community engagement.”

- Gov. Glenn Youngkin (R-Virginia) “When you are in the business of saving lives, you have to throw ‘impossible’ out the window and focus on ‘everything is possible.’ It’s possible when we work together towards a goal.

We want the best for all of our people, no matter their location, zip code, the color of their skin, who they pray to — they deserve the best. Massey is the best at what they do.”

- Levar M. Stoney, Mayor of Richmond, Virginia

“This wouldn’t have happened without the efforts of many people at Massey — the scientists, physicians, nurses, staff, students and trainees — everyone working together diligently to try and eradicate cancer in our community and our country.”

GORDON GINDER, M.D. FORMER MASSEY DIRECTOR AND MASSEY CLUB ENDOWED CHAIR

“Massey’s commitment to health equity is not an adjective; it’s a verb. We are excited and hopeful about this partnership and what it will bring, not just to our Tribal citizens, but to the broader Charles City County community.”

- Stephen Adkins, Chickahominy Indian Tribe Chief “When I reflect on the evolution of the cancer center over the years, I am honored to have led initiatives that continue to make an important impact on Massey and the communities it serves today. The establishment of the Massey Club, Bone Marrow Transplant Program, multidisciplinary clinics and cancer outreach program to rural Virginia are just a few that come to mind. As an NCI-designated Comprehensive Cancer Center, Massey’s impact will be elevated even further, and I feel a profound sense of pride and joy to have been a part of the center’s history and to celebrate this very important milestone!”

- I. David Goldman, M.D., former Massey director (1988-1997) | 49

Institutional leadership Michael Rao, Ph.D. President, VCU and VCU Health System Marlon Levy, M.D., M.B.A. Interim Senior Vice President, VCU Health Sciences Interim CEO, VCU Health System P. Srirama Rao, Ph.D. Vice President, Research & Innovation at VCU

Arturo Saavedra, M.D., Ph.D., M.B.A. Executive Vice President for Medical Affairs, VCU Health System Dean, VCU School of Medicine F. Gerard Moeller, M.D. Director, Wright Center for Clinical & Translational Research at VCU Elias Neujahr, M.H.A., M.B.A. President, Children’s Hospital of Richmond at VCU

Michael Roussos President, VCU Medical Center Michael Elliott, Pharm.D., MSHA, FACHE Chief Operating Officer, VCU Health System

Massey senior leadership (as of July 1, 2023) Robert A. Winn, M.D. Director, Massey Comprehensive Cancer Center

Andrew S. Poklepovic, M.D. Associate Director, Clinical Research

Paula M. Fracasso, M.D., Ph.D., FACP Deputy Director, Massey Comprehensive Cancer Center

Devanand Sarkar, M.B.B.S., Ph.D. Associate Director, Research Training & Education

Paul Fawcett, Ph.D. Associate Director, Shared Resources

Saïd Sebti, Ph.D. Associate Director, Basic Research

Bernard F. Fuemmeler, Ph.D., M.P.H. Associate Director, Population Sciences

Vanessa B. Sheppard, Ph.D. Interim Associate Director, Community Outreach & Engagement

Steven Grant, M.D. Associate Director, Translational Research

Emmanuel A. Taylor, M.Sc., Dr.P.H. Senior Director, Global Cancer Health Equity & Partnership

Michelle K. Lin, M.B.A Associate Director, Administration

Research program leadership Cancer Biology Azeddine Atfi, Ph.D. Paula D. Bos, Ph.D. Developmental Therapeutics Anthony C. Faber, Ph.D. Steven Grant, M.D. Xiang-Yang “Shawn” Wang, Ph.D. Cancer Prevention & Control Victoria J. Findlay, Ph.D. Oxana G. Palesh, Ph.D., M.P.H.

50 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Faith-based leadership Founding members Rudene Mercer Haynes, J.D. Partner, Hunton Andrews Kurth LLP

Members Jessica Young Brown, Ph.D., LCP Resident Therapist, Facts & Faith Fridays

Rev. F. Todd Gray Pastor, Fifth Street Baptist Church, Richmond, VA

Rev. Marvin Gilliam, Jr. Pastor, The Mount Carmel Baptist Church

Robert A. Winn, M.D. Director, VCU Massey Comprehensive Cancer Center

Rev. Dr. Cheryl Ivey Green Executive Minister, The First Baptist Church of South Richmond

Student representatives Pamela Adede Student, VCU

Dr. Dwight C. Jones Senior Pastor, The First Baptist Church of South Richmond

Kevin Babu Student, VCU Medical School

Rev. Rachel Pierce Faith Liaison & Engagement Coordinator, VCU Massey Comprehensive Cancer Center

Madisonne Jennings Student, Virginia State University

Dr. Herbert Ponder Pastor, Mount Tabor Baptist Church Rev. Dr. Jerome C. Ross Pastor, Providence Park Baptist Church Arnethea Sutton, Ph.D. Assistant Professor, Kinesiology & Health Sciences, VCU

Director’s Cabinet Father Shay Auerbach Jesuit Priest, Sacred Heart Catholic

Michael “Mickey” Hoffeister President, Massey Alliance Young Professionals Board

Victor Branch Senior Vice President, Bank of America

Riguey King Vice President of Community Impact, American Cancer Society

L.D. Britt, M.D. Vice Dean of Clinical Affairs, Eastern Virginia Medical School

James Millner Program Director of VA Pride, Diversity Richmond

Tracy Douglas-Wheeler CEO, Virginia Community Healthcare Association

Rev. Tyrone E. Nelson Vice Chairman, Henrico County Board of Supervisors

Bryan Ennis Vice President of Customer Experience Centers, CarMax

Erica Pitts Representative, Rappahannock Tribe

Mia Eubank Representative, Chickahominy Tribe

Kevin D. Smith Director of Legal Operations, Dominion Energy

Rev. Maurice A. Ferrell, Ph.D. Pastor, Vance Street Missionary Baptist Church

Rev. Leo Whitaker Executive Minister, Baptist General Convention of Virginia

L. Michael Gracik, Jr., CPA Immediate past Chair, Massey Advisory Board

Anne Whittemore Chair, Massey Advisory Board

Rudene Mercer Haynes, J.D. Partner, Hunton Andrews Kurth, LLP

| 51

Endowments Chairs Douglas W. Arthur, M.D. Florence and Hyman Meyers Chair in Radiation Oncology Charles V. Clevenger, M.D., Ph.D. Carolyn Wingate Hyde Endowed Chair in Cancer Research Paul Dent, Ph.D. Universal Corporation Chair in Cancer Cell Signaling Anthony C. Faber, Ph.D. Natalie N. and John R. Congdon, Sr., Endowed Chair in Cancer Research Paul B. Fisher, M.Ph., Ph.D. Thelma Newmeyer Corman Endowed Chair in Oncology Research Paula M. Fracasso, M.D., Ph.D., FACP Dianne Nunnally Hoppes Endowed Chair in Cancer Research Bernard F. Fuemmeler, Ph.D., M.P.H. Gordon D. Ginder M.D. Chair in Cancer Research Gordon D. Ginder, M.D. Massey Club Chair Steven Grant, M.D. Shirley Carter and Sture Gordon Olsson Chair in Cancer Research Suyun Huang, M.D., Ph.D. Paul M. Corman M.D. Chair in Cancer Research Joseph H. Laver, M.D. Children’s Hospital Endowed Chair in Pediatric Cancer Research Patrick Nana-Sinkam, M.D. Linda Grandis Blatt Endowed Chair in Cancer Research Oxana G. Palesh, Ph.D., M.P.H. Massey Cancer Center Chair in Cancer Research Saïd Sebti, Ph.D. Lacy Family Chair in Cancer Research Vanessa B. Sheppard, Ph.D. Theresa A. Thomas Memorial Foundation Chair in Cancer Prevention and Control Sarah Spiegel, Ph.D. Mann T. and Sara D. Lowry Chair in Oncology Robert A. Winn, M.D. Lipman Chair in Oncology Yuesheng Zhang, M.D., Ph.D. Harrigan, Haw and Luck Families Chair in Cancer Research

52 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Professorships Azeddine Atfi, Ph.D. Mary Anderson Harrison Distinguished Professorship in Cancer Research Laurence J. DiNardo, M.D. Darlene and George P. Emerson, Jr., Professorship in Cancer Research Susan Hong, M.D., M.P.H., FACP RGC Professorship for Cancer Research Renato G. Martins, M.D., M.P.H. Martha Anne Hatcher Distinguished Professorship in Oncology Leslie M. Randall, M.D. Dianne Harris Wright Professorship for the Division Director of Gynecologic Oncology at MCV-VCU Dianne Harris Wright Professorship for OB-GYN Oncology Research Devanand Sarkar, M.B.B.S., Ph.D. Harrison Foundation Distinguished Professorship in Cancer Research Jose G. Trevino, M.D., FACS Walter Lawrence, Jr., Distinguished Professorship in Oncology Xiang-Yang “Shawn” Wang, Ph.D. Harry and Judy Wason Distinguished Professorship Jolene J. Windle, Ph.D. Irene Shaw Grigg Distinguished Professorship in Genetics Research Active Recruitment C. Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research Judith Talley Secor Chair Thomas Palliative Care Endowed Chair Harrison Endowed Scholars Wook-Jin “Eddie” Chae, Ph.D. Sun Jung “Sunny” Kim, Ph.D., M.S., M.A Can Senkal, Ph.D. Katherine Y. Tossas, Ph.D., M.S.

Recruitment

In the last two years, Massey welcomed more than a dozen new research members. Faculty recruitment expands scientific expertise and improves care delivery across a range of diseases and research areas of focus.

James B. Burch, Ph.D. Professor, Family Medicine & Population Health Victoria J. Findlay, Ph.D. Associate Professor, Surgery Paula M. Fracasso, M.D., Ph.D., FACP Senior Vice President, Cancer Service Line Professor, Internal Medicine Susan Hong, M.D., M.P.H., FACP Associate Professor, Internal Medicine Raphael J. Louie, M.D., M.P.H. Assistant Professor, Surgery Keri R. Maher, D.O. Assistant Professor, Internal Medicine Renato G. Martins, M.D., M.P.H. Chair, Division of Hematology, Oncology & Palliative Care Professor, Internal Medicine Oxana G. Palesh, Ph.D., M.P.H. Professor, Psychiatry

Leslie M. Randall, M.D. Chair, Division of Gynecologic Oncology Professor, Obstetrics & Gynecology Emmanuel A. Taylor, M.Sc., Dr.P.H. Professor, Health Behavior & Policy Katherine Y. Tossas, Ph.D., M.S. Assistant Professor, Health Behavior & Policy Jose G. Trevino, M.D., FACS Chair, Division of Surgical Oncology Associate Professor, Surgery David P. Turner, Ph.D. Associate Professor, Surgery Nolan A. Wages, Ph.D. Professor, Biostatistics Hengbin Wang, Ph.D. Professor, Internal Medicine Yuesheng Zhang, M.D., Ph.D. Professor, Pharmacology & Toxicology

| 53

Fundraising boards Excellence requires excellent leaders, and at Massey, our volunteer leaders are at the heart of everything we do. Massey Advisory Board and Massey Alliance Young Professionals Board members are donors and advocates. They lead by example, provide philanthropic support and drive fundraising and engagement with members of our community to advance Massey’s mission.

Massey Advisory Board

We thank our volunteer leaders for their dedication and commitment.

Officers (FY21 & FY22) L. Michael Gracik, Jr., CPA, Chair Anne Whittemore, Vice Chair Members (FY21 & FY22) Dr. Ralph H. B. Anderson Shelly E. Arthur Ann H. Austin Catherine M. Bayliss Susan M. Benson Mary Bliley Roger L. Boevé Jean Ann Bolling Ellen T. Bonbright Judy S. Brown Charles L. Cabell Jill Thalhimer Campbell Theodore L. Chandler, Jr. Judith T. Clough David S. Cohn Jeffrey W. Congdon John R. Congdon, Jr. Joelle K. Cosby Sarah B. Cossé Paul W. Croston Brian Davis Preston Dillard James K. Donaldson George P. Emerson, Jr. Kathryn K. Funk Stephanie J. Gilliard, Esq. Cheryl G. Goddard Josh Goldschmidt Ann Parker H. Gottwald A. William Hamill Terrell L. Harrigan

54 |

Elizabeth S. Hart Rudene Mercer Haynes, J.D. Karen D. Higgins Connie Hom Eucharia Jackson Tracey W. Jameson

Lisa W. Sims Susan B. Sisisky Raymond M. Slabaugh III Vickie M. Snead Judith Forehand Starkey Elizabeth H. Thornton

Joseph R. Jenkins Martin K. Johnson Deborah J. Johnston Linwood A. Lacy, Jr. Betty Sue G. LePage* Gail L. Letts John B. Lewis Michelle K. Logan David A. Lyons Rebecca C. Massey Travis Massey Aaron McClung Patricia Merrill James S. Merritt Henry R. Miller Elizabeth B. Minter Brandon Moore

Christina E. Todd Robert G. Whitten Amy Williams

James T. Napier Mary Harvard Nolde William F. O’Keefe Carl E. Omohundro, Jr. Julian T. Ottley Kathryn H. Pearson Catherine Plotkin Anna W. Reed Jennifer Ronga Pamela K. Royall Helen J. Ryan Frances Santarella Dr. Travis L. Shaw

O’Conor G. Ashby, II Ben Barani Dorothy Erlanger Lisa S. Goodwin Julia Hammond Michael Hofmeister Mary Lawson Joey McCaffrey Brad Ozmore

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

Emeritus members William G. Broaddus Charles F. Crone James E. Farnham Alice T. Goodwin Adrienne Maxwell E. Morgan Massey * Bertha C. Rolfe * Judith Harris Turbeville Matthew G. Thompson Ex-officio members Ashley Allen

*Deceased

Massey Alliance Young Professionals Board

This group of young professionals support and raise awareness for research and resources at Massey through events, outreach and fundraising.

Executive committee (FY21) O’Conor G. Ashby, II, President Michael Hofmeister, President-Elect Executive committee (FY22) Michael Hofmeister, President Ben Barani, President-Elect Members (FY21 & FY22) Meredith Ascari Brigid Bucci Rachel Calvert Bryce Carson Timothy Cavazos Ernie Chamberlain Ashton Farrar Leanne Ferry Danielle Frazier Korey Gardner Dan Halloran Katie Jarvis

Andrea Kirkbride Mark Lynch Philip Matthews George Moore IV Rebecca Mullin Clint Nichols* Caitlin Noffsinger Lara Omick Megan Paulsen Yann Reichelt Andrew Russo Kassie Schroth Nicholas Shedd David Stabler Will Stallings Megan Sullivan Elliott Warren Sara Woznicki Emily Younts *Deceased

| 55

Virginia Commonwealth University Massey Comprehensive Cancer Center Box 980037 Richmond, VA 23298-0037

Contact (877) 4MASSEY AskMassey@vcu.edu MasseyCancerCenter.org

Support To make a financial contribution or to inquire about ways to support Massey, please contact the Office of Medical Philanthropy and Alumni Relations (804) 828-1450 TeamMassey@vcu.edu MasseyCancerCenter.org/support

Connect VCUMasseyCancerCenter VCU-Massey-Cancer-Center

56 |

MASSEY COMPREHENSIVE CANCER CENTER ANNUAL REPORT

VCUMassey TeamMassey